Hypertrophic Cardiomyopathy- The Case for Alcohol Ablation Therapy
DOI:
https://doi.org/10.2015/hc.v4i2.326Abstract
Non-surgical reduction of septal hypertrophy by means of transcoronary alcohol septal ablation has recently emerged as an alternative to surgical myectomy treatment modality in patients with obstructive hypertrophic cardiomyopathy (HCM) refractory to medical therapy. Advantages of the percutaneous ablation technique include the avoidance of a major surgical procedure, the lack of post-operative pain and need for transfusion, the shorter hospital stay and the low incidence of atrial fibrillation. However, until more comparative data between these two techniques become available, surgical myectomy remains the standard approach as the most effective and long-lasting treatment for alleviating symptoms of obstructive HCM.Downloads
Issue
Section
License
Authors who publish with this journal agree to the following terms:a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).